Comments
Pharmaceutical company Bafna has reported over 300 per cent increase on its standalone net profit for the quarter ending September 30,2012 at Rs 2.06 crore.
This was up by over 350 per cent from Rs 45.47 lakh registered during the corresponding period of previous year, the Chennai-based company said in a filing to the BSE today.
The standalone total income from operations of the company for the period ending September 30, 2012 rose by 63.6 per cent to Rs 58.19 crore from Rs 35.55 crore registered during the same period of last year.
Shares of the company remain unchanged at Rs 47 apiece in the BSE.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.